What is CUE's dilution risk score?

CUE has a latest available DilutionScore record of 79/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CUE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CUE?

DilutionWatch tracks 25 SEC filing types for CUE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CUE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CUE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CUE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CUE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CUE Dilution Risk Score: 79/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

85

📊 Float Risk

50

⚠️ Warrant Exposure

30

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 25%

💰 Capital Raise model 35%

• Low cash runway: 5 months remaining

📜 Warrant Exercise model 15%

• Warrant overhang: 7.6% of shares outstanding

📉 Score Deterioration model 15%

• Score already CRITICAL (79/100) — events likely imminent

🔔 Track CUE — Get forecast alerts →

Market Data

Market Cap$88.60M

Shares Outstanding7.26M

Float3.61M

Cash$17.39M

Debt$4.00M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 8.9% shares (2026Q1 vs prior)

55 institutional holders · 24.09M shares

#1 Bleichroeder LP 6.82M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 4.91M shares

#3 GC Wealth Management RIA, LLC 4.63M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest349.9K

Days to Cover1.9

% of Float9.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CUE Dilution Snapshot

Cue Biopharma, Inc. (CUE) has a DilutionScore of 79/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 551,724.
Recent SEC activity tracked for CUE: xbrl on 2026-06-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.